- Previous Close
50.48 - Open
53.00 - Bid 53.00 x --
- Ask --
- Day's Range
53.00 - 53.00 - 52 Week Range
42.00 - 88.70 - Volume
431 - Avg. Volume
1,526 - Market Cap (intraday)
133.512M - Beta (5Y Monthly) 0.32
- PE Ratio (TTM)
27.75 - EPS (TTM)
1.91 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Colinz Laboratories Limited manufactures, markets, and trades in pharmaceutical formulations in India. The company offers pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, and creams, etc.; and specialized products for gynecology, cardiology, and gastroenterology, etc. Its allopathy products include oncology products, such as imitinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, doxorubicin, filgrastim, and pegylated liposome doxorubicin, etc.; antiritrovirals, including lopinavir, indinavir, ritonavir, darunavir, zidovudine, lamivudin, and various combination therapy products; and products for other therapeutic areas, such as antibiotics, anti-fungals, anti-malarials, anti-virals, anti-manics, anti-convulsants, anti-migraines, anti-allergics, anthelmintics, anti-emetics, sedatives, cerebral activators, ulcer healing agents, laxatives, probiotics, digestive enzymes, topical steroids, ear/eye drops, hormones, sunscreens, and vitamins, etc., as well as drugs used in protozoal infestations and neuropathy. In addition, the company offers ayurvedic products comprising anti-diarrhoeals, anti-pyretics, anti-inflammatories, anti-spasmodics, cough syrups, appetite stimulating agents, memory boosters, anti-piles, antacids, liver tonics, ulcer healing agents, digestive agents, uterine tonics, anti-diabetics, and general tonics, as well as drugs to treat oligospermia and erectile dysfunction. Further, it provides nutraceuticals, including spirulina tabs/caps, spirulina with vitamins and minerals, omega 3 fatty acids caps in softgel, codliver oil with vitamin caps in soft gel, amino acids tabs/caps, l-arginine with proantocyanidin granules, and hair growth formulations, etc., as well as collagen, glucosamine, and chondroitin tabs. Colinz Laboratories Limited was incorporated in 1986 and is based in Mumbai, India.
www.colinz.com69
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: COLINZ.BO
View MorePerformance Overview: COLINZ.BO
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: COLINZ.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: COLINZ.BO
View MoreValuation Measures
Market Cap
127.16M
Enterprise Value
54.87M
Trailing P/E
26.43
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.90
Price/Book (mrq)
1.36
Enterprise Value/Revenue
0.82
Enterprise Value/EBITDA
6.45
Financial Highlights
Profitability and Income Statement
Profit Margin
7.19%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
67.06M
Net Income Avi to Common (ttm)
4.82M
Diluted EPS (ttm)
1.91
Balance Sheet and Cash Flow
Total Cash (mrq)
80.41M
Total Debt/Equity (mrq)
8.68%
Levered Free Cash Flow (ttm)
--